130 related articles for article (PubMed ID: 28216224)
1. Targeted proteomics driven verification of biomarker candidates associated with breast cancer aggressiveness.
Procházková I; Lenčo J; Fučíková A; Dresler J; Čápková L; Hrstka R; Nenutil R; Bouchal P
Biochim Biophys Acta Proteins Proteom; 2017 May; 1865(5):488-498. PubMed ID: 28216224
[TBL] [Abstract][Full Text] [Related]
2. Targeted Proteomics Driven Verification of Biomarker Candidates Associated with Breast Cancer Aggressiveness.
Procházková I; Lenčo J; Bouchal P
Methods Mol Biol; 2018; 1788():177-184. PubMed ID: 29196895
[TBL] [Abstract][Full Text] [Related]
3. Combined Proteomics and Transcriptomics Identifies Carboxypeptidase B1 and Nuclear Factor κB (NF-κB) Associated Proteins as Putative Biomarkers of Metastasis in Low Grade Breast Cancer.
Bouchal P; Dvořáková M; Roumeliotis T; Bortlíček Z; Ihnatová I; Procházková I; Ho JT; Maryáš J; Imrichová H; Budinská E; Vyzula R; Garbis SD; Vojtěšek B; Nenutil R
Mol Cell Proteomics; 2015 Jul; 14(7):1814-30. PubMed ID: 25903579
[TBL] [Abstract][Full Text] [Related]
4. Transgelin is upregulated in stromal cells of lymph node positive breast cancer.
Dvořáková M; Jeřábková J; Procházková I; Lenčo J; Nenutil R; Bouchal P
J Proteomics; 2016 Jan; 132():103-11. PubMed ID: 26639304
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of periostin is positively associated with gastric cancer metastasis through promoting tumor metastasis and invasion.
Zhong H; Li X; Zhang J; Wu X
J Cell Biochem; 2019 Jun; 120(6):9927-9935. PubMed ID: 30637809
[TBL] [Abstract][Full Text] [Related]
6. Stathmin1 expression is associated with aggressive phenotypes and cancer stem cell marker expression in breast cancer patients.
Obayashi S; Horiguchi J; Higuchi T; Katayama A; Handa T; Altan B; Bai T; Bao P; Bao H; Yokobori T; Nishiyama M; Oyama T; Kuwano H
Int J Oncol; 2017 Sep; 51(3):781-790. PubMed ID: 28766688
[TBL] [Abstract][Full Text] [Related]
7. Identification and prognostic value of anterior gradient protein 2 expression in breast cancer based on tissue microarray.
Guo J; Gong G; Zhang B
Tumour Biol; 2017 Jul; 39(7):1010428317713392. PubMed ID: 28671019
[TBL] [Abstract][Full Text] [Related]
8. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
[TBL] [Abstract][Full Text] [Related]
9. Specific upregulation of RHOA and RAC1 in cancer-associated fibroblasts found at primary tumor and lymph node metastatic sites in breast cancer.
Rozenchan PB; Pasini FS; Roela RA; Katayama ML; Mundim FG; Brentani H; Lyra EC; Brentani MM
Tumour Biol; 2015 Dec; 36(12):9589-97. PubMed ID: 26142737
[TBL] [Abstract][Full Text] [Related]
10. Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients.
Esteban JM; Felder B; Ahn C; Simpson JF; Battifora H; Shively JE
Cancer; 1994 Sep; 74(5):1575-83. PubMed ID: 7914825
[TBL] [Abstract][Full Text] [Related]
11. Increased circulating resistin levels in early-onset breast cancer patients of normal body mass index correlate with lymph node negative involvement and longer disease free survival: a multi-center POSH cohort serum proteomics study.
Zeidan B; Manousopoulou A; Garay-Baquero DJ; White CH; Larkin SET; Potter KN; Roumeliotis TI; Papachristou EK; Copson E; Cutress RI; Beers SA; Eccles D; Townsend PA; Garbis SD
Breast Cancer Res; 2018 Mar; 20(1):19. PubMed ID: 29566726
[TBL] [Abstract][Full Text] [Related]
12. Proteomics Identification and Validation of Desmocollin-1 and Catechol-O-Methyltransferase as Proteins Associated with Breast Cancer Cell Migration and Metastasis.
Faktor J; Knopfova L; Lapcik P; Janacova L; Paralova V; Bouchalova P; Muller P; Benes P; Bouchal P
Proteomics; 2019 Nov; 19(21-22):e1900073. PubMed ID: 31617665
[TBL] [Abstract][Full Text] [Related]
13. LAPTM4B Predicts Axillary Lymph Node Metastasis in Breast Cancer and Promotes Breast Cancer Cell Aggressiveness in Vitro.
Xiao M; Yang S; Meng F; Qin Y; Yang Y; Jia S; Cai X; Li C; Huang Y; Ning X
Cell Physiol Biochem; 2017; 41(3):1072-1082. PubMed ID: 28245476
[TBL] [Abstract][Full Text] [Related]
14. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
[TBL] [Abstract][Full Text] [Related]
15. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.
Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015
[TBL] [Abstract][Full Text] [Related]
16. Epithelial periostin expression is correlated with poor survival in patients with invasive breast carcinoma.
Kim GE; Lee JS; Park MH; Yoon JH
PLoS One; 2017; 12(11):e0187635. PubMed ID: 29161296
[TBL] [Abstract][Full Text] [Related]
17. PPFIA1 is upregulated in liver metastasis of breast cancer and is a potential poor prognostic indicator of metastatic relapse.
Yang J; Wu NN; Huang DJ; Luo YC; Huang JZ; He HY; Lu HL; Song WL
Tumour Biol; 2017 Jul; 39(7):1010428317713492. PubMed ID: 28720060
[TBL] [Abstract][Full Text] [Related]
18. Ep-CAM RNA expression predicts metastasis-free survival in three cohorts of untreated node-negative breast cancer.
Schmidt M; Petry IB; Böhm D; Lebrecht A; von Törne C; Gebhard S; Gerhold-Ay A; Cotarelo C; Battista M; Schormann W; Freis E; Selinski S; Ickstadt K; Rahnenführer J; Sebastian M; Schuler M; Koelbl H; Gehrmann M; Hengstler JG
Breast Cancer Res Treat; 2011 Feb; 125(3):637-46. PubMed ID: 20352488
[TBL] [Abstract][Full Text] [Related]
19. IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype.
Walter O; Prasad M; Lu S; Quinlan RM; Edmiston KL; Khan A
Hum Pathol; 2009 Nov; 40(11):1528-33. PubMed ID: 19695680
[TBL] [Abstract][Full Text] [Related]
20. Low mutation and neoantigen burden and fewer effector tumor infiltrating lymphocytes correlate with breast cancer metastasization to lymph nodes.
Wang Z; Liu W; Chen C; Yang X; Luo Y; Zhang B
Sci Rep; 2019 Jan; 9(1):253. PubMed ID: 30670769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
